WORX
WORX
SCWorx Corp.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $744.9K ▼ | $210.24K ▼ | $-173.77K ▲ | -23.33% ▲ | $-0.16 ▲ | $35.06K ▲ |
| Q4-2025 | $768.9K ▲ | $542.84K ▲ | $-749.18K ▲ | -97.44% ▲ | $-0.71 ▲ | $-614.03K ▼ |
| Q3-2025 | $705.8K ▲ | $390.78K ▼ | $-1.31M ▲ | -185.96% ▲ | $-2.25 ▲ | $2.29M ▲ |
| Q2-2025 | $682.63K ▼ | $473.94K ▲ | $-1.91M ▼ | -279.23% ▼ | $-6.9 ▼ | $-371.63K ▼ |
| Q1-2025 | $720.3K | $470.86K | $-476.3K | -66.13% | $-3.75 | $-334K |
What's going well?
The company cut its losses sharply this quarter and improved gross margins to 50%. Operating expenses dropped, showing better cost control.
What's concerning?
Revenue is slipping, and the company is still losing money. The big jump in share count means existing shareholders own a much smaller piece of the company.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.34M ▼ | $7.78M ▼ | $726.9K ▼ | $7.05M ▼ |
| Q4-2025 | $1.64M ▲ | $7.9M ▲ | $743.6K ▼ | $7.15M ▲ |
| Q3-2025 | $684.29K ▲ | $7.18M ▲ | $1.18M ▼ | $6M ▲ |
| Q2-2025 | $340.21K ▼ | $6.65M ▼ | $1.2M ▼ | $5.45M ▼ |
| Q1-2025 | $1.07M | $7.16M | $1.56M | $5.59M |
What's financially strong about this company?
No debt at all, and enough cash to cover near-term bills. The company is not at risk of a cash crunch and has a clean balance sheet with no hidden liabilities.
What are the financial risks or weaknesses?
Most of the company's assets are intangible (goodwill), which could be written down if acquisitions don't perform. Retained earnings are deeply negative, showing a history of losses, and cash is trending down.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-173.77K ▲ | $-252.75K ▼ | $-65.41K ▼ | $15.5K ▼ | $-302.66K ▼ | $-252.75K ▼ |
| Q4-2025 | $-749.18K ▲ | $-129.08K ▲ | $-30.64K ▼ | $1.12M ▲ | $960.14K ▲ | $-139.7K ▲ |
| Q3-2025 | $-1.31M ▲ | $-358.08K ▲ | $0 | $702.17K ▲ | $344.09K ▲ | $-358.08K ▲ |
| Q2-2025 | $-1.91M ▼ | $-651.83K ▼ | $0 | $-80.37K ▼ | $-732.21K ▼ | $-651.83K ▼ |
| Q1-2025 | $-476.3K | $-404.62K | $0 | $1.37M | $965.76K | $-404.62K |
What's strong about this company's cash flow?
Net losses are shrinking, and the company is not taking on debt. No capital spending means low fixed costs.
What are the cash flow concerns?
Cash burn is rising, and with no new fundraising, cash reserves are dropping fast. The company will need more money soon to keep operating.
Revenue by Products
| Product | Q1-2018 | Q2-2018 |
|---|---|---|
Athlete Management | $0 ▲ | $0 ▲ |
Corporate Segment | $0 ▲ | $0 ▲ |
Promotion Segment | $0 ▲ | $0 ▲ |
Ticket Service Segment | $0 ▲ | $0 ▲ |
5-Year Trend Analysis
A comprehensive look at SCWorx Corp.'s financial evolution and strategic trajectory over the past five years.
Key positives include a specialized SaaS offering that targets a real and costly pain point for hospitals—data fragmentation and supply chain inefficiency. The company demonstrates a workable gross margin structure, strong short-term liquidity, low traditional debt, and a net cash position. Its product strategy, centered on a comprehensive, interoperable data platform with modular components, provides a clear narrative and potential for sticky customer relationships. These elements together give SCWorx a foundation for potential growth if it can execute commercially and operationally.
The most important risks are financial: substantial operating and net losses, negative cash flow from operations, and reliance on external financing to grow or even maintain operations. Deeply negative retained earnings and an asset base dominated by goodwill and other intangibles highlight a history of losses and potential vulnerability to future write-downs. Competitive risks are also significant, given the presence of much larger healthcare IT players and the company’s small scale and limited brand recognition. If revenue growth does not accelerate or costs are not meaningfully reduced, the current model may prove difficult to sustain over time.
Looking ahead, SCWorx’s outlook hinges on its ability to translate its specialized technology and data platform into a broader, more profitable customer base before financial flexibility tightens. The strong liquidity position buys some time, but ongoing cash burn and high financing costs create pressure to show operational improvement. In a favorable scenario, increased adoption, better cost control, and deeper partnerships could gradually move the company toward a self-sustaining model. In a less favorable scenario, continued losses and competitive headwinds could force strategic changes, restructurings, or additional capital raises under potentially less attractive terms. Overall, the future path remains uncertain and will be driven primarily by execution, customer traction, and cost discipline.
About SCWorx Corp.
https://www.scworx.comSCWorx Corp., headquartered in New York, New York, is a technology firm primarily dedicated to crafting and marketing advanced information technology solutions and related services for the healthcare industry. Its central aim is to enhance operational efficiency and streamline data flow within hospitals and various medical establishments across the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $744.9K ▼ | $210.24K ▼ | $-173.77K ▲ | -23.33% ▲ | $-0.16 ▲ | $35.06K ▲ |
| Q4-2025 | $768.9K ▲ | $542.84K ▲ | $-749.18K ▲ | -97.44% ▲ | $-0.71 ▲ | $-614.03K ▼ |
| Q3-2025 | $705.8K ▲ | $390.78K ▼ | $-1.31M ▲ | -185.96% ▲ | $-2.25 ▲ | $2.29M ▲ |
| Q2-2025 | $682.63K ▼ | $473.94K ▲ | $-1.91M ▼ | -279.23% ▼ | $-6.9 ▼ | $-371.63K ▼ |
| Q1-2025 | $720.3K | $470.86K | $-476.3K | -66.13% | $-3.75 | $-334K |
What's going well?
The company cut its losses sharply this quarter and improved gross margins to 50%. Operating expenses dropped, showing better cost control.
What's concerning?
Revenue is slipping, and the company is still losing money. The big jump in share count means existing shareholders own a much smaller piece of the company.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.34M ▼ | $7.78M ▼ | $726.9K ▼ | $7.05M ▼ |
| Q4-2025 | $1.64M ▲ | $7.9M ▲ | $743.6K ▼ | $7.15M ▲ |
| Q3-2025 | $684.29K ▲ | $7.18M ▲ | $1.18M ▼ | $6M ▲ |
| Q2-2025 | $340.21K ▼ | $6.65M ▼ | $1.2M ▼ | $5.45M ▼ |
| Q1-2025 | $1.07M | $7.16M | $1.56M | $5.59M |
What's financially strong about this company?
No debt at all, and enough cash to cover near-term bills. The company is not at risk of a cash crunch and has a clean balance sheet with no hidden liabilities.
What are the financial risks or weaknesses?
Most of the company's assets are intangible (goodwill), which could be written down if acquisitions don't perform. Retained earnings are deeply negative, showing a history of losses, and cash is trending down.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $-173.77K ▲ | $-252.75K ▼ | $-65.41K ▼ | $15.5K ▼ | $-302.66K ▼ | $-252.75K ▼ |
| Q4-2025 | $-749.18K ▲ | $-129.08K ▲ | $-30.64K ▼ | $1.12M ▲ | $960.14K ▲ | $-139.7K ▲ |
| Q3-2025 | $-1.31M ▲ | $-358.08K ▲ | $0 | $702.17K ▲ | $344.09K ▲ | $-358.08K ▲ |
| Q2-2025 | $-1.91M ▼ | $-651.83K ▼ | $0 | $-80.37K ▼ | $-732.21K ▼ | $-651.83K ▼ |
| Q1-2025 | $-476.3K | $-404.62K | $0 | $1.37M | $965.76K | $-404.62K |
What's strong about this company's cash flow?
Net losses are shrinking, and the company is not taking on debt. No capital spending means low fixed costs.
What are the cash flow concerns?
Cash burn is rising, and with no new fundraising, cash reserves are dropping fast. The company will need more money soon to keep operating.
Revenue by Products
| Product | Q1-2018 | Q2-2018 |
|---|---|---|
Athlete Management | $0 ▲ | $0 ▲ |
Corporate Segment | $0 ▲ | $0 ▲ |
Promotion Segment | $0 ▲ | $0 ▲ |
Ticket Service Segment | $0 ▲ | $0 ▲ |
5-Year Trend Analysis
A comprehensive look at SCWorx Corp.'s financial evolution and strategic trajectory over the past five years.
Key positives include a specialized SaaS offering that targets a real and costly pain point for hospitals—data fragmentation and supply chain inefficiency. The company demonstrates a workable gross margin structure, strong short-term liquidity, low traditional debt, and a net cash position. Its product strategy, centered on a comprehensive, interoperable data platform with modular components, provides a clear narrative and potential for sticky customer relationships. These elements together give SCWorx a foundation for potential growth if it can execute commercially and operationally.
The most important risks are financial: substantial operating and net losses, negative cash flow from operations, and reliance on external financing to grow or even maintain operations. Deeply negative retained earnings and an asset base dominated by goodwill and other intangibles highlight a history of losses and potential vulnerability to future write-downs. Competitive risks are also significant, given the presence of much larger healthcare IT players and the company’s small scale and limited brand recognition. If revenue growth does not accelerate or costs are not meaningfully reduced, the current model may prove difficult to sustain over time.
Looking ahead, SCWorx’s outlook hinges on its ability to translate its specialized technology and data platform into a broader, more profitable customer base before financial flexibility tightens. The strong liquidity position buys some time, but ongoing cash burn and high financing costs create pressure to show operational improvement. In a favorable scenario, increased adoption, better cost control, and deeper partnerships could gradually move the company toward a self-sustaining model. In a less favorable scenario, continued losses and competitive headwinds could force strategic changes, restructurings, or additional capital raises under potentially less attractive terms. Overall, the future path remains uncertain and will be driven primarily by execution, customer traction, and cost discipline.

CEO
Timothy Andrew Hannibal
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-04-10 | Reverse | 1:15 |
| 2023-10-11 | Reverse | 1:15 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-

